tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR

Nektar Therapeutics (NKTR) Similar Stocks

Compare
1,259 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nektar Therapeutics
$0.96
$176.51M
35.07%
4 Buy
0 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$20.29
$3.38B
26.27
-18.42%
5 Buy
5 Hold
0 Sell
Moderate Buy
Alkermes
$35.50
$5.77B
16.29
19.45%
8 Buy
3 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$68.73
$12.36B
39.51
-22.37%
18 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$35.09
$9.57B
19.79
69.35%
12 Buy
8 Hold
0 Sell
Moderate Buy
Incyte
$71.38
$13.79B
258.70
18.32%
6 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
NKTR
Nektar Therapeutics
0.93
0.27
40.91%
ACAD
ACADIA Pharmaceuticals
20.29
-4.56
-18.35%
ALKS
Alkermes
35.32
6.41
22.17%
BMRN
BioMarin Pharmaceutical
68.73
-21.24
-23.61%
EXEL
Exelixis
35.09
14.38
69.44%
INCY
Incyte
71.38
10.47
17.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis